Cyclezyme reported no revenue and continued operating losses, but achieved a major breakthrough in PET recycling technology and filed a new patent for a highly efficient enzyme. Liquidity remains strong, supporting ongoing R&D and commercialization efforts.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.